Avantor Stock Earnings Reports

Q1 highlights and investor takeaways: Avantor delivered Q1 results ahead of internal expectations despite continued organic revenue declines. Total revenue was $1.581 billion (down ~4% organic), adjusted EBITDA was $219 million (13.9% margin) and adjusted EPS was $0.17. Key segment details: VWR Distribution & Services generated $1.15 billion (‑5% organic) but showed stabilization and early e‑commerce improvements after platform upgrades and the relaunch of vwr.com. Bioscience & Medtech Products (BMP) reported $431 million (‑2% organic); process chemicals showed double‑digit growth, BMP book‑to‑bill exceeded 1.1x, and operational stability is improving. Cash and leverage: free cash flow was $25 million in Q1 ($39 million ex‑restructuring), about $105 million of debt was repaid and adjusted net leverage was 3.3x. Guidance and outlook: the company reaffirmed 2026 guidance, expects Q2 adjusted EPS of $0.19–$0.20, and reiterated its priority to reduce leverage sustainably below 3.0x. Management expects VWR growth to have troughed in Q1 and BMP growth to trough in Q2, positioning the company to return to organic revenue growth in H2 2026. Risks/headwinds: management is incorporating an estimated $10–$20 million 2026 operating‑income headwind from inflationary pressures tied to the Middle East conflict and has a task force to mitigate impacts. Revival program actions: ~25% of senior leadership refreshed, kaizen/lean initiatives and targeted CapEx projects (including modular automation) underway to improve operations, margins and productivity. Overall message: stabilization is visible, operational recovery is in progress, and management is focused on execution, margin improvement, deleveraging and returning to growth in H2.